Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Beers

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
The Journal of Clinical Investigation|July 22, 2009
Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cellsAndrei Ivanov, Stephen A Beers, Claire A Walshe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 12, 2011
Interaction with FcγRIIB is critical for the agonistic activity of anti-CD40 monoclonal antibodyAnn L White, H T Claude Chan, Ali Roghanian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 13, 2013
Immunotherapy targeting inhibitory Fcγ receptor IIB (CD32b) in the mouse is limited by monoclonal antibody consumption and receptor internalizationEmily L Williams, Alison L Tutt, Stephen A Beers, et al.
Cancer Immunology Research|August 28, 2019
Cyclophosphamide Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR ExpressionAli Roghanian, Guangan Hu, Christopher Fraser, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environmentsJulia Moreno-Vicente, Jane E Willoughby, Martin C Taylor, et al.
Cancer Research|May 18, 2017
STING Activation Reverses Lymphoma-Mediated Resistance to Antibody ImmunotherapyLekh N Dahal, Lang Dou, Khiyam Hussain, et al.
Breast Cancer Research : BCR|March 24, 2018
Increased circulating resistin levels in early-onset breast cancer patients of normal body mass index correlate with lymph node negative involvement and longer disease free survival: a multi-center POSH cohort serum proteomics studyBashar Zeidan, Antigoni Manousopoulou, Diana J Garay-Baquero, et al.
NAR Cancer|January 2, 2026
Replication-associated base excision repair/single-strand break repair regulates PARG inhibitor response via the PRMT1/PRMT5/ATR axisMd Ibrahim, Wynand P Roos, Jacob C Schwartz, et al.
Communications Biology|March 15, 2022
Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineeringFranziska Heckel, Anna H Turaj, Hayden Fisher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2006
The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20Jessica L Teeling, Wendy J M Mackus, Luus J J M Wiegman, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Investigation|July 22, 2009
Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cellsAndrei Ivanov, Stephen A Beers, Claire A Walshe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 12, 2011
Interaction with FcγRIIB is critical for the agonistic activity of anti-CD40 monoclonal antibodyAnn L White, H T Claude Chan, Ali Roghanian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 13, 2013
Immunotherapy targeting inhibitory Fcγ receptor IIB (CD32b) in the mouse is limited by monoclonal antibody consumption and receptor internalizationEmily L Williams, Alison L Tutt, Stephen A Beers, et al.
Cancer Immunology Research|August 28, 2019
Cyclophosphamide Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR ExpressionAli Roghanian, Guangan Hu, Christopher Fraser, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environmentsJulia Moreno-Vicente, Jane E Willoughby, Martin C Taylor, et al.
Cancer Research|May 18, 2017
STING Activation Reverses Lymphoma-Mediated Resistance to Antibody ImmunotherapyLekh N Dahal, Lang Dou, Khiyam Hussain, et al.
Breast Cancer Research : BCR|March 24, 2018
Increased circulating resistin levels in early-onset breast cancer patients of normal body mass index correlate with lymph node negative involvement and longer disease free survival: a multi-center POSH cohort serum proteomics studyBashar Zeidan, Antigoni Manousopoulou, Diana J Garay-Baquero, et al.
NAR Cancer|January 2, 2026
Replication-associated base excision repair/single-strand break repair regulates PARG inhibitor response via the PRMT1/PRMT5/ATR axisMd Ibrahim, Wynand P Roos, Jacob C Schwartz, et al.
Communications Biology|March 15, 2022
Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineeringFranziska Heckel, Anna H Turaj, Hayden Fisher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2006
The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20Jessica L Teeling, Wendy J M Mackus, Luus J J M Wiegman, et al.
Pageof 11